Related references
Note: Only part of the references are listed.Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study
Kristina E. Rudd et al.
LANCET (2020)
SEQUENTIAL CHANGES OF NLRP3 INFLAMMASOME ACTIVATION IN SEPSIS AND ITS RELATIONSHIP WITH DEATH
Jose Garnacho-Montero et al.
SHOCK (2020)
Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department
Ioannis M. Zacharioudakis et al.
PLOS ONE (2019)
Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications
Cheng Zeng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Biomarkers in Sepsis
Tjitske S. R. van Engelen et al.
CRITICAL CARE CLINICS (2018)
Epidemiology and Costs of Sepsis in the United StatesAn Analysis Based on Timing of Diagnosis and Severity Level*
Carly J. Paoli et al.
CRITICAL CARE MEDICINE (2018)
The role of mitochondria in NLRP3 inflammasome activation
Qiuyun Liu et al.
MOLECULAR IMMUNOLOGY (2018)
The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection
Amanda Costa Goncalves et al.
IMMUNOLOGY (2017)
Gasdermin: A new player to the inflammasome game
Erivan S. Ramos et al.
BIOMEDICAL JOURNAL (2017)
NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B4 Synthesis
Seonmin Lee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
Altaf Afrasyab et al.
HEART AND VESSELS (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Gene silencing of non-obese diabetic receptor family (NLRP3) protects against the sepsis-induced hyper-bile acidaemia in a rat model
Y. Wu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Pyroptotic cell death defends against intracellular pathogens
Ine Jorgensen et al.
IMMUNOLOGICAL REVIEWS (2015)
NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin
Mamoru Satoh et al.
CLINICAL SCIENCE (2014)
Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012
Kirsi-Maija Kaukonen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
Fei Zheng et al.
HEART LUNG AND CIRCULATION (2013)
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Richard S. Hotchkiss et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Understanding the mechanism of IL-1β secretion
Gloria Lopez-Castejon et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
Edward A. Miao et al.
NATURE IMMUNOLOGY (2010)
Inflammasome mRNA expression in human monocytes during early septic shock
Ruairi J. Fahy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the International Sepsis Forum
JC Marshall et al.
CRITICAL CARE MEDICINE (2005)
Share Paper
